Showing 11-20 of 25 results for "".
HCM: Understanding the condition
https://pace-cme.org/programs/cme/HCM_Understanding_the_condition/16546/This educational program consists of three presentations on hypertrophic cardiomyopathy (HCM).Diagnosing HCM: What a cardiologist needs to know
https://pace-cme.org/programs/cme/Diagnosing_HCM_What_a_cardiologist_needs_to_know/16547/This educational program consists of three presentations on hypertrophic cardiomyopathy (HCM).- Cardiac myosin inhibitor reduces need for septal reduction therapy in obstructive HCMhttps://pace-cme.org/congress-coverage/acc22/cardiac-myosin-inhibitor-reduces-need-for-septal-reduction-therapy-in-obstructive-hcm/17498/3' education - Apr. 2, 2022 - Prof. Milind Desai, MD
- Emerging therapies in HCM: The potential role of cardiac myosin inhibitorshttps://pace-cme.org/topics/hypertrophic-cardiomyopathy/emerging-therapies-in-hcm-the-potential-role-of-cardiac-myosin-inhibitors/17528/10' education - May 4, 2022 - Ahmad Masri, MD and prof. Deepak Bhatt, MD
HCM and heart failure: is your patient at risk?
https://pace-cme.org/programs/cme/hcm-and-heart-failure-your-patient-risk/16265/This educational program consists of three presentations on HF and HCM.Recognizing HCM and HF: making the diagnosis
https://pace-cme.org/programs/cme/recognizing-hcm-and-hf-making-the-diagnosis/16266/This educational program consists of three presentations on HF and HCM.- Impact of new first-in-class medical therapy in obstructive HCMhttps://pace-cme.org/topics/hypertrophic-cardiomyopathy/impact-of-new-first-in-class-medical-therapy-in-obstructive-hcm/17500/3' education - Apr. 3, 2022 - Joseph Cleveland, MD
Managing patients with HCM and HF: what’s new in the therapeutic landscape?
https://pace-cme.org/programs/cme/managing-patients-with-hcm-and-hf-what-s-new-in-the-therapeutic-landscape/16267/This educational program consists of three presentations on HF and HCM.- Cardiac myosin inhibitor is safe and effective in HCM in phase 2 trialhttps://pace-cme.org/congress-coverage/esc-heart-failure-2023/cardiac-myosin-inhibitor-is-safe-and-effective-in-hcm-in-phase-2-trial/17702/3' education - June 1, 2023 - Ahmad Masri, MD
- Cardiac myosin inhibitor sustainably reduces LVOT gradient in HCMhttps://pace-cme.org/topics/hypertrophic-cardiomyopathy/cardiac-myosin-inhibitor-sustainably-reduces-lvot-gradient-in-hcm/17504/3' education - Apr. 4, 2022 - Maya Guglin, MD, PhD